Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Hepatology (Baltimore, Md.)
|
November 11, 2009
Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008
David B Rein, Sarah B Lesesne, Ann O'Fallon, et al.
Hepatology (Baltimore, Md.)
|
December 29, 2015
The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics
David B Rein, Joshua Borton, Danielle K Liffmann, et al.
Ophthalmic Epidemiology
|
September 27, 2007
Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches
David B Rein, Kathleen E Wirth, Chris A Johnson, et al.
Public Health Reports (Washington, D.C. : 1974)
|
August 2, 2011
Models of community-based hepatitis B surface antigen screening programs in the U.S. and their estimated outcomes and costs
David B Rein, Sarah B Lesesne, Bryce D Smith, et al.
Ophthalmology
|
March 24, 2018
Establishing a Vision and Eye Health Surveillance System for the Nation: A Status Update on the Vision and Eye Health Surveillance System
David B Rein, John S Wittenborn, Emily A Phillips, et al.
American Journal of Public Health
|
July 29, 2006
Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage
David B Rein, Amanda A Honeycutt, Lucia Rojas-Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 26, 2026
Performance of ICD-10 code-based dementia case definition in the Health and Retirement Study
Kan Z Gianattasio, Michael Steffan, Ben Reist, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
September 1, 2011
The potential cost-effectiveness of amblyopia screening programs
David B Rein, John S Wittenborn, Xinzhi Zhang, et al.
Hepatology (Baltimore, Md.)
|
November 29, 2011
The global burden of hepatitis E virus genotypes 1 and 2 in 2005
David B Rein, Gretchen A Stevens, Jordan Theaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 18, 2015
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus
David B Rein, John S Wittenborn, Bryce D Smith, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Hepatology (Baltimore, Md.)
|
November 11, 2009
Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008
David B Rein, Sarah B Lesesne, Ann O'Fallon, et al.
Hepatology (Baltimore, Md.)
|
December 29, 2015
The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics
David B Rein, Joshua Borton, Danielle K Liffmann, et al.
Ophthalmic Epidemiology
|
September 27, 2007
Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches
David B Rein, Kathleen E Wirth, Chris A Johnson, et al.
Public Health Reports (Washington, D.C. : 1974)
|
August 2, 2011
Models of community-based hepatitis B surface antigen screening programs in the U.S. and their estimated outcomes and costs
David B Rein, Sarah B Lesesne, Bryce D Smith, et al.
Ophthalmology
|
March 24, 2018
Establishing a Vision and Eye Health Surveillance System for the Nation: A Status Update on the Vision and Eye Health Surveillance System
David B Rein, John S Wittenborn, Emily A Phillips, et al.
American Journal of Public Health
|
July 29, 2006
Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage
David B Rein, Amanda A Honeycutt, Lucia Rojas-Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 26, 2026
Performance of ICD-10 code-based dementia case definition in the Health and Retirement Study
Kan Z Gianattasio, Michael Steffan, Ben Reist, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
September 1, 2011
The potential cost-effectiveness of amblyopia screening programs
David B Rein, John S Wittenborn, Xinzhi Zhang, et al.
Hepatology (Baltimore, Md.)
|
November 29, 2011
The global burden of hepatitis E virus genotypes 1 and 2 in 2005
David B Rein, Gretchen A Stevens, Jordan Theaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 18, 2015
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus
David B Rein, John S Wittenborn, Bryce D Smith, et al.
Page
of 9